FDA - International Biopharmaceutical Industry

news

FDA rejects a biotech’s kidney drug, but some analysts still see a ‘sliver of hope’

The FDA's decision wasn't surprising to analysts, as "deficiencies" in an approval application have become somewhat of a prelude to rejection. This year alone saw two...

5 August 2021 news Acadia Pharmaceuticals | Ardelyx

Continue Reading →

news

AstraZeneca wins first FDA approval for systemic lupus drug in a decade

Benlysta's approval was itself a landmark, being the first such drug approved in decades. Its use has grown slowly and steadily over time, falling just shy of blockbu...

5 August 2021 news AstraZeneca | Benlysta

Continue Reading →

news

FDA rejects Insys opioid pain spray

Insys Therapeutics said Friday that the Food and Drug Administration issued it a Complete Response Letter rejecting the company’s New Drug Application for Buvaya. ...

31 July 2018 news FDA | insys

Continue Reading →

news

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

BIO hits its goal Three days into the BIO International convention, the industry group touted breaking the G...

8 June 2018 news BIO | BIO18

Continue Reading →

news

TherapeuticsMD garners FDA OK for Imvexxy

TherapeuticsMD got a green light from the Food and Drug Administration for TX-004HR, a treatment for moderate-to-severe dyspareunia, or vaginal pain during sexual...

1 June 2018 news FDA | Imvexxy

Continue Reading →

news

FDA launches medical device ‘innovation challenge’ to combat opioid crisis

The Food and Drug Administration announced Wednesday an “innovation challenge" aimed at encouraging the development of medical devices such as digital hea...

1 June 2018 news challenge | combat

Continue Reading →

news

Gene Therapies That Could Transform Diseases Get Easier FDA Path

New therapies that may cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administr...

25 May 2018 news diseases | easier

Continue Reading →

Current Edition

Upcoming Events

Advertisement

FDA rejects a biotech’s kidney drug, but some analysts still see a ‘sliver of hope’

AstraZeneca wins first FDA approval for systemic lupus drug in a decade

FDA rejects Insys opioid pain spray

BIO18: Pfizer (sort of) inches back to neuro; Building ties with FDA

TherapeuticsMD garners FDA OK for Imvexxy

FDA launches medical device ‘innovation challenge’ to combat opioid crisis

Gene Therapies That Could Transform Diseases Get Easier FDA Path

International Biopharmaceutical Industry